Best Buy to sell over-the-counter hearing devices this fall following change in FDA regulation

Best Buy to sell over-the-counter hearing devices this fall following change in FDA regulation


Black Friday shoppers leave a Best Buy store in Washington, DC, on November 26, 20221.

Nicholas Kamm | AFP | Getty Images

Best Buy said Wednesday that it will offer an expanded collection of hearing products and services this fall after federal regulators said they would begin allowing sales of over-the-counter hearing devices.

By fall, the Minneapolis-based company said 300 of its more than 1,000 stores will have hearing solutions displays with about 10 hearing devices available at each. The electronic products retailer said it has already started offering an online hearing assessment tool.

The push by Best Buy comes after the U.S. Food and Drug Administration this week greenlit sales of over-the-counter hearing devices, which the agency said will let people with mild to moderate hearing loss buy devices from retailers without needing a medical exam, prescription, or fitting adjustment. The FDA will still regulate the quality of the OTC devices, which it said could be available as early as mid-October when the rule takes effect.

Hearing aids that are intended for severe hearing impairment or for people younger than 18 still require prescriptions.

The FDA said the new rule is expected to lower the cost of hearing aids. Nearly 30 million adults in the U.S. could benefit from hearing aids, according the agency.

Best Buy has sold hearing devices including personal sound amplification products, TV amplifiers and hearing protection devices, but the new category of OTC devices opens the door for new products. 

Customers will be able to use health savings accounts and flexible spending accounts to purchase devices. Best Buy recommends checking with insurance providers to confirm the devices are covered.

“Our expansion of the hearing collection and new store experience will let customers easily find a hearing loss solution from brands they trust,” said Frank Bedo, category officer at Best Buy, in a statement.

Best Buy was down around 2% in pre-market trading. 



Source

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market
Health

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market

The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next chapter. Patients are already getting their hands on the first GLP-1 pill for obesity from Danish drugmaker Novo Nordisk — a once-daily drug that shares the same brand name as its popular injection Wegovy. […]

Read More
Healthy Returns: What to expect from pharma at the JPM conference
Health

Healthy Returns: What to expect from pharma at the JPM conference

Heidi Overton, Novo Nordisk CEO Maziar Mike Doustdar, Eli Lilly CEO David A. Ricks, and U.S. Secretary of Commerce Howard Lutnick listen while U.S. President Donald Trump announces a deal with Eli Lilly and Novo Nordisk on to reduce the prices of GLP-1 weight‑loss drugs during an event in the Oval Office at the White […]

Read More
A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
Health

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year

Europe’s best-performing blue-chip stock in 2025 is widely expected to be bought by a larger peer, in a deal analysts say could be worth as much as $23 billion. Abivax, the French clinical-stage biotech company developing a treatment for ulcerative colitis and Crohn’s disease, saw shares rocket 1,681% last year, far outpacing the Stoxx 600 […]

Read More